Ohh M - Search Results

1

HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D.

Toschi A, Edelstein J, Rockwell P, Ohh M, Foster DA. Toschi A, et al. Among authors: ohh m. Oncogene. 2008 Apr 24;27(19):2746-53. doi: 10.1038/sj.onc.1210927. Epub 2007 Nov 12. Oncogene. 2008. PMID: 17998935

2

Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway.

Chung J, Roberts AM, Chow J, Coady-Osberg N, Ohh M. Chung J, et al. Among authors: ohh m. Oncogene. 2006 May 18;25(21):3079-83. doi: 10.1038/sj.onc.1209328. Oncogene. 2006. PMID: 16407835

3

Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2.

Toschi A, Lee E, Gadir N, Ohh M, Foster DA. Toschi A, et al. Among authors: ohh m. J Biol Chem. 2008 Dec 12;283(50):34495-9. doi: 10.1074/jbc.C800170200. Epub 2008 Oct 22. J Biol Chem. 2008. PMID: 18945681 Free PMC article.

4

Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.

Roberts AM, Watson IR, Evans AJ, Foster DA, Irwin MS, Ohh M. Roberts AM, et al. Among authors: ohh m. Cancer Res. 2009 Dec 1;69(23):9056-64. doi: 10.1158/0008-5472.CAN-09-1770. Epub 2009 Nov 17. Cancer Res. 2009. PMID: 19920202 Free PMC article.

5

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

Toschi A, Lee E, Thompson S, Gadir N, Yellen P, Drain CM, Ohh M, Foster DA. Toschi A, et al. Among authors: ohh m. Cancer Lett. 2010 Dec 18;299(1):72-9. doi: 10.1016/j.canlet.2010.08.006. Cancer Lett. 2010. PMID: 20805015 Free PMC article.

6

K63-ubiquitylation of VHL by SOCS1 mediates DNA double-strand break repair.

Metcalf JL, Bradshaw PS, Komosa M, Greer SN, Stephen Meyn M, Ohh M. Metcalf JL, et al. Among authors: ohh m. Oncogene. 2014 Feb 20;33(8):1055-65. doi: 10.1038/onc.2013.22. Epub 2013 Mar 4. Oncogene. 2014. PMID: 23455319

7

A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells.

Patel D, Salloum D, Saqcena M, Chatterjee A, Mroz V, Ohh M, Foster DA. Patel D, et al. Among authors: ohh m. J Biol Chem. 2017 Jan 20;292(3):936-944. doi: 10.1074/jbc.M116.757864. Epub 2016 Dec 12. J Biol Chem. 2017. PMID: 27956548 Free PMC article.

8

The HIF and other quandaries in VHL disease.

Tarade D, Ohh M. Tarade D, et al. Among authors: ohh m. Oncogene. 2018 Jan 11;37(2):139-147. doi: 10.1038/onc.2017.338. Epub 2017 Sep 18. Oncogene. 2018. PMID: 28925400 Review.

9

von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG Jr. Hoffman MA, et al. Among authors: ohh m. Hum Mol Genet. 2001 May 1;10(10):1019-27. doi: 10.1093/hmg/10.10.1019. Hum Mol Genet. 2001. PMID: 11331612

10

Expression of p53 in renal carcinoma cells is independent of pVHL.

Stickle NH, Cheng LS, Watson IR, Alon N, Malkin D, Irwin MS, Ohh M. Stickle NH, et al. Among authors: ohh m. Mutat Res. 2005 Oct 15;578(1-2):23-32. doi: 10.1016/j.mrfmmm.2005.02.016. Epub 2005 Jul 5. Mutat Res. 2005. PMID: 15998523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters